A patient-derived organoid model identifies TP53-dependent gemcitabine sensitivity in spinal chordoma
{{output}}
Background: Chordoma is a rare malignant bone tumor with limited effective systemic treatment options. Conventional chemotherapy generally shows minimal benefit, highlighting the need for predictive preclinical models to explore ... ...
